Webcast Replay Now Available for Moleculin Biotech’s Quarterly Conference Call and Live Audio Webcast

Better
Treatments,
More Tomorrows

Better
Treatments,
More Tomorrows

We Are
Advancing

a growing pipeline of product candidates for the treatment of highly resistant cancers and viruses.

Innovative
Therapies

through the use of proprietary technologies and data to develop a next generation anthracycline, immune/transcription modulators (STAT3 inhibitors) and metabolism/glycosylation inhibitors.

Innovative
Therapies

through the use of proprietary technologies and data to develop a next generation anthracycline, immune/transcription modulators (STAT3 inhibitors) and metabolism/glycosylation inhibitors.

Priority Development Pipeline

Latest Releases

Stock Information

NASDAQ: MBRX

NASDAQ: MBRX

Corporate

Presentation

Corporate

Presentation